Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Duflot

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Thrombolysis|February 1, 2019
Thrombin generation profile in non-thrombotic factor V Leiden carriersPaul Billoir, Thomas Duflot, Marielle Fresel, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 29, 2021
Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteersThomas Duflot, Tony Pereira, Marie-Pierre Tavolacci, et al.
Atherosclerosis|July 7, 2018
Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during agingJulien Wils, Zoubir Djerada, Frederic Roca, et al.
Anaesthesia, Critical Care & Pain Medicine|February 8, 2026
Linezolid use in Postoperative Central Nervous System Infections: a Pharmacokinetic Simulation-based Approach for Critically Ill PatientsCharles Baulier, Marion Giry, Paul Lozé, et al.
Frontiers in Molecular Biosciences|March 29, 2021
Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal SyndromeMouad Hamzaoui, Clothilde Roche, David Coquerel, et al.
Metabolites|September 23, 2022
Determination of Lipoxygenase, CYP450, and Non-Enzymatic Metabolites of Arachidonic Acid in Essential Hypertension and Type 2 DiabetesGuillaume Feugray, Tony Pereira, Michèle Iacob, et al.
Atherosclerosis|August 2, 2023
Changes in carotid arterial wall viscosity and carotid arterial stiffness in type 2 diabetes patientsFrédéric Roca, Louise Zmuda, Gabrielle Noël, et al.
Clinical Pharmacokinetics|January 11, 2023
Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane OxygenationPierre Bourgoin, Jules Lecomte, Mehdi Oualha, et al.
Analytical Chemistry|April 8, 2020
Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis PatientsDongyang Li, Christophe Morisseau, Cindy B McReynolds, et al.
Fundamental & Clinical Pharmacology|January 11, 2018
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three casesThomas Duflot, Aude Marie-Cardine, Céline Verstuyft, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Thrombolysis|February 1, 2019
Thrombin generation profile in non-thrombotic factor V Leiden carriersPaul Billoir, Thomas Duflot, Marielle Fresel, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 29, 2021
Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteersThomas Duflot, Tony Pereira, Marie-Pierre Tavolacci, et al.
Atherosclerosis|July 7, 2018
Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during agingJulien Wils, Zoubir Djerada, Frederic Roca, et al.
Anaesthesia, Critical Care & Pain Medicine|February 8, 2026
Linezolid use in Postoperative Central Nervous System Infections: a Pharmacokinetic Simulation-based Approach for Critically Ill PatientsCharles Baulier, Marion Giry, Paul Lozé, et al.
Frontiers in Molecular Biosciences|March 29, 2021
Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal SyndromeMouad Hamzaoui, Clothilde Roche, David Coquerel, et al.
Metabolites|September 23, 2022
Determination of Lipoxygenase, CYP450, and Non-Enzymatic Metabolites of Arachidonic Acid in Essential Hypertension and Type 2 DiabetesGuillaume Feugray, Tony Pereira, Michèle Iacob, et al.
Atherosclerosis|August 2, 2023
Changes in carotid arterial wall viscosity and carotid arterial stiffness in type 2 diabetes patientsFrédéric Roca, Louise Zmuda, Gabrielle Noël, et al.
Clinical Pharmacokinetics|January 11, 2023
Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane OxygenationPierre Bourgoin, Jules Lecomte, Mehdi Oualha, et al.
Analytical Chemistry|April 8, 2020
Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis PatientsDongyang Li, Christophe Morisseau, Cindy B McReynolds, et al.
Fundamental & Clinical Pharmacology|January 11, 2018
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three casesThomas Duflot, Aude Marie-Cardine, Céline Verstuyft, et al.
Pageof 5